This is the 19th volume, 12th issue of the EPVC’s monthly newsletter, published in December 2025. It serves as an official communication from the Egyptian Drug Authority (EDA) to healthcare professionals, regulators, and the public regarding drug safety, pharmacovigilance activities, and regulatory updates in Egypt.
By integrating Directed Acyclic Graphs (DAGs) from causal inference into pharmacovigilance practice, the authors provide a structured way to map, understand, and mitigate the biases that have long plagued signal detection.
Every year on February 4th, the world unites under the banner of World Cancer Day. This global initiative, led by the Union for International Cancer Control (UICC), aims to raise awareness, improve education, and catalyze personal, collective, and government action to reimagine a world where millions of preventable cancer deaths are avoided and...
The State of Kuwait has established a robust and structured pharmacovigilance (PV) system, detailed comprehensively in the Kuwait Good Pharmacovigilance Practice (KuGVP) guidelines. This framework aligns Kuwait with international standards while addressing local regulatory needs, positioning the country as a committed guardian of patient safety.
Neglected Tropical Diseases (NTDs) remain a stark marker of global health inequity, affecting over 1.5 billion of the world's poorest and most marginalized people. The Global Report on Neglected Tropical Diseases 2025 by the World Health Organization (WHO) charts two decades of concerted action, revealing significant victories alongside persistent and emerging challenges.
The era of one-size-fits-all medicine is rapidly giving way to a more precise, personalized approach, thanks to the field of pharmacogenomics (PGx). Pharmacogenomics, a cornerstone of personalized medicine, studies how an individual's genetic makeup influences their response to medications.
Vaccine safety refers to the scientific and medical standards applied to ensure vaccines are as free from risk as possible while providing significant protection against infectious diseases.
Advancing Medication Safety Through Knowledge and Vigilance
